Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease

about

Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease

Item

http://www.wikidata.org/entity/Q59153352

description

scientific article published on 02 November 2016

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2016

@uk

name

Impact of disease duration and ...... tension in Parkinson's disease

@en

Impact of disease duration and ...... tension in Parkinson's disease

@nl

type

Item

label

Impact of disease duration and ...... tension in Parkinson's disease

@en

Impact of disease duration and ...... tension in Parkinson's disease

@nl

prefLabel

Impact of disease duration and ...... tension in Parkinson's disease

@en

Impact of disease duration and ...... tension in Parkinson's disease

@nl

P1476

Impact of disease duration and ...... tension in Parkinson's disease

@en

P2093

Alice Laudisio

http://www.w3.org/2001/XMLSchema#string

Giuseppe Zuccalà

http://www.w3.org/2001/XMLSchema#string

Graziano Onder

http://www.w3.org/2001/XMLSchema#string

Maria R Lo Monaco

http://www.w3.org/2001/XMLSchema#string

Maria S Pisciotta

http://www.w3.org/2001/XMLSchema#string

Paolo D L'Angiocola

http://www.w3.org/2001/XMLSchema#string

Vincenzo Brandi

http://www.w3.org/2001/XMLSchema#string

P2860

The contribution of white matter lesions (WML) to Parkinson's disease cognitive impairment symptoms: A critical review of the literature.

Nicotine as a potential neuroprotective agent for Parkinson's disease.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Dysautonomia in Parkinson disease

Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson's disease.

Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease.

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

Clinical characteristics of Parkinson's disease patients in Greece: a multicenter, nation-wide, cross-sectional study.

Changing relationship among clinic, home, and ambulatory blood pressure with increasing age.

Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease.

P304

418-423

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCH.12938

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anna Rita Bentivoglio

Davide L Vetrano

Domenico Fusco

R Bernabei

P577

2016-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27804276

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease